Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)

Phase Distribution

Ph not_applicable
3
50%
Ph phase_2
2
33%
Ph early_phase_1
1
17%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Other(1)

Detailed Status

Completed5
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (16.7%)
Phase 22 (33.3%)
N/A3 (50.0%)

Trials by Status

unknown117%
completed583%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
6